Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Pevonedistat (MLN4924), a First‐in‐Class NEDD8‐activating... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Pevonedistat (MLN4924), a First‐in‐Class NEDD8‐activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: a phase 1 study
0
Authors
Ronan Swords
12 more
Ronan Swords
•
Harry Erba
10 more
•
Bruno Medeiros
Published
March 2, 2015
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
British Journal of Haematology
Topics
Medicine
Internal Medicine
Hematology
Molecular Biology
Myeloid
Show all topics
DOI
10.1111/bjh.13323
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
British Journal of Haematology
Topics
Medicine
Internal Medicine
Hematology
Molecular Biology
Myeloid
Show all topics
DOI
10.1111/bjh.13323
Other Formats
PDF
